Moderna plans to test booster shots of the Covid-19 vaccine one year after the first two doses, as the protection period from the new vaccine is still unknown.
According to this week’s corporate presentation, biotechnology companies are set to begin testing in July. According to an email shared by one of those people, the clinical trial site has already begun to contact participants in previous studies.
“So far, we expect vaccination to last for at least a year,” Modana’s chief medical officer, Dr. Talzax, told investors and analysts at the JP Morgan Healthcare Conference on Monday. “Make database recommendations to the extent that you need booster shots. To do that, you need to get the data.”
The first participants in the Moderna human clinical trial received a shot in mid-March. 1 second was given after 4 weeks. Because previous trials tested multiple doses of the vaccine, lower doses of the vaccine (100 micrograms) got boosters sooner than the final approved one, and trials over 100 micrograms marked the year. Get a booster at. Email the participants.
The booster currently planned is the same version as the vaccine on the market, but Moderna CEO Stephane Bancel said the vaccine may need to be adjusted to cover the new variant. It was.
“I think this will be a flu-like market,” he told CNBC. Moderna has also recently launched a seasonal flu vaccine program.
At this week’s meeting, Bansel said the Modana Covid-19 vaccine booster study would assess both safety and the amount of immune response generated by additional injections a year later.
Moderna appears to test Covid-19 booster shots one year after the first vaccination
Source link Moderna appears to test Covid-19 booster shots one year after the first vaccination